Drug General Information (ID: DDIDTARQ18)
Drug Name			Lidocaine		Drug Info		Raloxifene		Drug Info
Drug Type		Small molecule				Small molecule
Therapeutic Class		Anesthetics				Hormones/Antineoplastics
Structure

Mechanism of Lidocaine-Raloxifene Interaction (Severity Level: Minor)
Competitive binding of plasma proteins Click to Show/Hide Mechanism Graph
Drug Name		Lidocaine				Raloxifene
Mechanism		Competition for plasma protein binding sites				Competition for plasma protein binding sites
Key Mechanism Factor 1
		Factor Name		Plasma protein binding
		Factor Description		Plasma protein binding refers to the degree of binding of a drug to proteins in the blood, and the lower the degree of binding, the more efficiently the drug can cross cell membranes or diffuse. Plasma protein binding alters the distribution and therapeutic characteristics of the drugs.
Mechanism Description		Increased plasma concentration of Raloxifene and Lidocaine due to competitive binding of plasma proteins

References
1	Product Information. Evista (raloxifene). Lilly, Eli and Company, Indianapolis, IN.